PTHLH and hypercalcemia disease: Osteolytic tumors display upregulation of PTHrP and RANKL, parathyroid hormone related protein acts via its receptor to induce a release of calcium into the circulation via bone resorption while acting in the kidney to suppress the excretion of excess calcium resulting in hypercalcemia.